Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Virginia Hospital Indicted for Fraud

Jan 31, 2025 | Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, White Collar Crime

Earlier this month, the Department of Justice announced that it had indicted the Chesapeake Regional Medical Center (CRMC) with healthcare fraud and conspiracy in relation to unnecessary gynecological and other procedures performed by one of its employed physicians....

Maryland Man Convicted in $20 Million Insurance Fraud Case

Jan 28, 2025 | Fraud Investigations

On January 24, 2025, the Department of Justice announced that James Wilson, a Maryland resident, was convicted of charges related to an alleged $20 million insurance fraud scheme. A federal jury found Wilson guilty of conspiracy to commit insurance fraud, money...

Pfizer Settles Allegations of Paying Kickbacks to Doctors to Promote Nurtec ODT

Jan 27, 2025 | Fraud Investigations

Pharmaceutical giant Pfizer Inc., through its subsidiary Biohaven Pharmaceutical, has agreed to a $59.7 million settlement to resolve allegations of submitting false Medicare claims by paying kickbacks to healthcare providers. These kickbacks were allegedly intended...

Annual Defense Appropriations Legislation Brings Major Changes to Administrative False Claim Act

Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025.  This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961.  Generally speaking, the NDAA governs Department of...

Biopharmaceutical Company Agrees to Pay Over $4M to Resolve Allegations of NIH Grant Fraud

Jan 8, 2025 | False Claims Act, Fraud Investigations

Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...

Stem Cell Manufacture to Serve 3 Years in Prison for Misrepresenting Product Safety and Efficacy

Oct 2, 2024 | Fraud Investigations

The DOJ announced that John W. Kosolcharoen, founder and chief executive officer of Liveyon LLC and Genetech Inc., was sentenced to 3 years in federal prison for one count of introducing an unapproved new drug into interstate commerce with the intent to defraud and...
« Older Entries
Next Entries »

Recent Posts

  • DOJ & DHS Partner on Trade Fraud Task Force
  • Florida Attorney General Files False Claims Act Lawsuit Against Textbook Publishers
  • State False Claims Acts and Their Role in Fraud Enforcement
  • Serial FCA Relator Scores Yet Another Massive PPP Loan Settlement
  • False Claims Act Risks for Healthcare Private Equity Investors

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group